PMC:7156903 / 5055-5298 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T46","span":{"begin":40,"end":47},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"False negatives from viral nucleic acid testing arise from the uneven quantity of detection technology, disease characteristics (asymptomatic patients), and status of epidemic prevention and control, as well as errors in clinical sampling [5]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T10","span":{"begin":27,"end":39},"obj":"Chemical"},{"id":"T11","span":{"begin":35,"end":39},"obj":"Chemical"}],"attributes":[{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"}],"text":"False negatives from viral nucleic acid testing arise from the uneven quantity of detection technology, disease characteristics (asymptomatic patients), and status of epidemic prevention and control, as well as errors in clinical sampling [5]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T35","span":{"begin":0,"end":243},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"False negatives from viral nucleic acid testing arise from the uneven quantity of detection technology, disease characteristics (asymptomatic patients), and status of epidemic prevention and control, as well as errors in clinical sampling [5]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"116","span":{"begin":142,"end":150},"obj":"Species"}],"attributes":[{"id":"A116","pred":"tao:has_database_id","subj":"116","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"False negatives from viral nucleic acid testing arise from the uneven quantity of detection technology, disease characteristics (asymptomatic patients), and status of epidemic prevention and control, as well as errors in clinical sampling [5]."}